GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report) shares passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.00 and traded as high as $0.00. GB Sciences shares last traded at $0.00, with a volume of 15,815 shares.
GB Sciences Price Performance
About GB Sciences
GB Sciences, Inc, a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs.
Read More
- Five stocks we like better than GB Sciences
- Ride Out The Recession With These Dividend Kings
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- The Role Economic Reports Play in a Successful Investment Strategy
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
